Thursday, December 28, 2017 6:50:15 PM
Toronto, Ontario--(Newsfile Corp. - December 22, 2017) - VITALHUB CORP. (TSXV: VHI) (the "Company" or "Vitalhub"), is pleased to announce that it has entered into a definitive acquisition agreement (the "Agreement") dated December 21, 2017 with all of the shareholders of H.I. Next Inc. ("HI Next") to purchase all of the issued and outstanding securities of HI Next (the "Acquisition"). The Acquisition is expected to close on or about December 29, 2017.
The purchase price for the Acquisition shall be up to $6,612,512 (the "Purchase Price"), satisfied by (i) a cash payment of $550,000 (the "Cash Purchase Price"), (ii) the delivery of a total of 19,500,000 common shares of Vitalhub ("Common Shares"), at a deemed price of $0.1275 per Common Share (the "Share Purchase Price"), to the shareholders of HI Next, and (iii) subject to the exercise of an option by a customer of HI Next on or after closing of the Acquisition, cash payments equal to certain fee(s) actually paid by such customer to HI Next pursuant to an existing agreement between such customer and HI Next, the aggregate of such payments not to exceed $2,784,817 (USD).
The Company currently has 102,857,974 Common Shares issued and outstanding. Upon delivery of the Share Purchase Price, the Company will have a total 122,357,974 issued and outstanding Common Shares. The principal shareholders of HI Next, Peter Catford and Ellen Catford (the "Principals") shall receive 9,078,876 and 8,722,840 Common Shares, respectively. Peter Catford and Ellen Catford are therefore receiving Common Shares of the Company such that they will hold approximately 7.42% and 7.13%, respectively, and 14.55% taken together, of the total issued and outstanding Common Shares on consummation of the Acquisition.
A portion of the Cash Purchase Price, being $150,000, will be subject to escrow for the purposes of use against future indemnity claims or purchase price adjustments and will be held for a period of nine (9) months from the date of closing of the Acquisition. A portion of the Share Purchase Price paid to the Principals, being 17,801,720 Common Shares, will be subject to escrow and is to be released bi-annually in six equal amounts over the period of three (3) years beginning with the date that is six (6) months after the date of closing.
The Agreement was negotiated at arm's length, and includes contains customary representations, warranties and closing conditions.
On closing of the Acquisition, Mr. Catford is to join Vitalhub's management as Chief Strategist.
The Acquisition remains subject to requisite regulatory approval, including the approval of the TSX Venture Exchange (the "TSXV") and satisfaction of closing conditions contained in the Agreement.
About HI Next
HI Next is a growing company which has historical revenues of $2.695 million, $3.329 million and $3.572 million for the previous three fiscal years (2015, 2016 and 2017), respectively with expenses for the corresponding periods of $2.530 million, $2,.953 million and $3.657 million. HI Next's fiscal year end is September 30.
HI Next offers a complete suite of industry proven, peer reviewed tools to identify and address the full range of behavioral, medical, and social problems affecting the seriously mental ill. Providers can document, share, and collaborate patient results, care plans, and progress notes with peer providers in real-time.
HI Next owns TREAT, a Web-based EHR and care coordination platform built for health care providers. TREAT's integrated solutions are tailored to many sectors of care, including Behavioral and Mental Health, Community, & more. With over 100 clinical assessment tools, coordinated care planning, progress notes, practice management and an easy-to-use design, TREAT provides a complete system that will help health care providers to improve overall patient care.
Currently more than 80 organizations across North America benefit from using TREAT's integrated health care solutions every day.
About VitalHub
VitalHub delivers an innovate platform for the creation of mobile health applications that increases productivity within healthcare settings. The VitalHub platform provides the ability to integrate existing individual healthcare applications while maintaining the control, security and privacy essential in healthcare. VitalHub's applications are focused on the fast-growing mental health and long term care markets and the company plans to strategically acquire and grow business in these areas. Currently over 50 healthcare institutions across Canada use products from VitalHub and its subsidiaries. of-definitive-agreement-for-acquisition-of-h-i#bV8RZfsjXkvfMl1l.99
Recent VHI News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:16:59 PM
- VALHI REPORTS FOURTH QUARTER 2023 RESULTS • GlobeNewswire Inc. • 03/07/2024 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:17:01 PM
- VALHI DECLARES QUARTERLY DIVIDEND • GlobeNewswire Inc. • 02/29/2024 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 09:39:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 09:16:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 09:15:51 PM
- VALHI REPORTS THIRD QUARTER 2023 RESULTS • GlobeNewswire Inc. • 11/06/2023 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 08:19:31 PM
- VALHI DECLARES QUARTERLY DIVIDEND • GlobeNewswire Inc. • 11/02/2023 08:15:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/02/2023 08:00:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 08:19:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/03/2023 08:18:48 PM
- VALHI DECLARES QUARTERLY DIVIDEND • GlobeNewswire Inc. • 08/03/2023 08:17:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/03/2023 08:15:50 PM
- VALHI REPORTS SECOND QUARTER 2023 RESULTS • GlobeNewswire Inc. • 08/03/2023 08:15:00 PM
- UPDATE--VALHI ANNOUNCES QUARTERLY CASH DIVIDEND AND RESULTS OF ANNUAL STOCKHOLDER MEETING • GlobeNewswire Inc. • 05/25/2023 09:09:58 PM
- VALHI ANNOUNCES QUARTERLY CASH DIVIDEND AND RESULTS OF ANNUAL STOCKHOLDER MEETING • GlobeNewswire Inc. • 05/25/2023 08:15:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM